Anti-inflammatory effects of a novel peptide designed to bind with NF-κB p50 subunit

Acta Pharmacologica Sinica

Volumn 27, Issue 11, 2006, Pages 1474-1478

  Wang, Zhen Ping ^a   Cai, Shao Xi ^a   Liu, Dong Bo ^b   Xu, Xiang ^b   Liang, Hua Ping ^b  

^a CHONGQING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammatory agents; Cytokines; NF B

Indexed keywords

CYSTEINYLPROLYLVALYLISOLEUCYLARGINYLHISTIDINE; GLYCYLARGINYLLYSYLLYSYLARGINYLARGINYLGLUTAMYLARGINYLARGINYLARGINYLPROLYLPROLYLGLUTAMINE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOSENSOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; EAR DISEASE; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERITONITIS; PROTEIN BINDING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BINDING SITES; BIOSENSING TECHNIQUES; CELL LINE, TUMOR; EDEMA; HUMANS; INTERLEUKIN-6; LEUKEMIA, MONOCYTIC, ACUTE; MICE; MICE, INBRED BALB C; NF-KAPPA B P50 SUBUNIT; PEPTIDES; PERITONITIS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 33750372570     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00442.x     Document Type: Article

References (19)

1. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-83.
2. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-55.
3. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
4. Ganchi PA, Sun SC, Greene WC, Ballard DW. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell 1992; 3: 1339-52.
5. Parry GC, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20 823-5.
6. Ernst MK, Dunn LL, Rice NR. The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol 1995; 15: 872-82.
7. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-63.
8. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995; 80: 529-32.
9. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994; 78: 773-85.
10. Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 2005; 5: 435-45.
11. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002; 9: 625-36.
12. Latimer M, Ernst MK, Dunn LL, Drutskaya M, Rice NR. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers. Mol Cell Biol 1998; 18: 2640-9.
13. Johnson C, van Antwerp D, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J 1999; 18: 6682-93.
14. Huxford T, Huang DB, Malek S, Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998; 95: 759-70.
15. May MJ, D'Acquisto F, Madge LA, Glöckner J, Pober JS, Ghosh S. Selective Inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 2000; 289: 1550-4.
16. Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985; 17: 197-204.
17. Ajuebor MN, Virag L, Flower RJ, Perretti M, Szabo C. Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology 1998; 95: 625-30.
18. Getting SJ, Flower RJ, Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol 1997; 120: 1075-82.
19. Wang CY, Guttridge DC, Mayo MW, Baldwin AS Jr. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19: 5923-9.